Founded in 2015 by Professor Andrew Mearns Spragg, a Scottish marine biotechnology pioneer, Jellagen is a marine biotechnology company manufacturing Collagen Type 0 for medical and scientific research applications. It is our deep belief in building sustainable sources for critical biomaterials which do not carry the environmental and human health risks of traditional collagen sources.
Since 2015, Jellagen has honed its proprietary technology, enhanced its product range, and extended its expertise.
Illex Squid Landings Surpass 150,000 Tons in Argentina Argentina
With a stable season and rising market prices, Illex cements its role amid global shortages of other squid species
The 2025 fishing season for Argentine shortfin squid (Illex argentinus) is showing s...
British Seafood Takes Off in South Korea, Fueled by Mackerel Boom South Korea
Surge Driven by New Mackerel Trade and FTA Benefits, Reshaping Market Dynamics Despite Average Price Drop
SEOUL – United Kingdom seafood exports to South Korea have experienced an extraord...
Oil in the Peruvian Sea: Devil's Excrement? Peru
The announcement of new oil findings off the Peruvian coast reopens a crucial debate about the country's energy, environmental, and productive future, confronting economic potential with the well-foun...
Coastal Waters Losing Acidity Buffer Due to Climate Change Norway
Warmer, wetter winters lead to increased freshwater runoff, weakening the ocean's natural ability to neutralize carbon dioxide and causing faster acidification along coastlines, according to research ...
Copyright 1995 - 2025 Seafood Media Group Ltd.| All Rights Reserved. DISCLAIMER
Jellagen Pty Ltd
Shareholder companies:
Print
